perinatologyРоссийский вестник перинатологии и педиатрииRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)1027-40652500-2228Ltd. “The National Academy of Pediatric Science and Innovation”10.21508/1027-4065-2021-66-6-6-16perinatology-1523Research ArticleПЕРЕДОВАЯEDITORIALВакцинация недоношенных детейImmunization of preterm infantshttps://orcid.org/0000-0002-4256-3237ФлоринскаяЕ. Б.FlorinskayaE. B.

Флоринская Евгения Борисовна – врач педиатр-неонатолог

143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2, корп. 2

Moscow region

jeniafl@yandex.ruhttps://orcid.org/0000-0001-6268-7782КешишянЕ. С.KeshishyanE. S.

Кешишян Елена Соломоновна – д.м.н., проф., рук. Центра коррекции развития детей раннего возраста Научно-исследовательского клинического института педиатрии им. академика Ю.Е. Вельтищева, главный педиатр Ильинской больницы

125412 Москва, ул. Талдомская, д. 2

Moscow

АО «Ильинская больница»РоссияIlyinskaya HospitalRussian FederationАО «Ильинская больница»; ОСП «Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева» ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РоссииРоссияIlyinskaya Hospital; Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical UniversityRussian Federation202118012022666616Copyright © Ltd. “The National Academy of Pediatric Science and Innovation”, 20222022Ltd. “The National Academy of Pediatric Science and Innovation”Ltd. “The National Academy of Pediatric Science and Innovation”https://www.ped-perinatology.ru/jour/about/submissions#copyrightNoticehttps://www.ped-perinatology.ru/jour/article/view/1523

В обзоре анализируются особенности вакцинации недоношенных детей. Данная тема крайне актуальна в Российской Федерации в связи с большим количеством медицинских отводов. На основании современных научных данных выявлены сложности иммунизации недоношенных, приводящие к необоснованной задержке вакцинации, оценены безопасность и эффективность вакцинации недоношенных. Доказано, что организм недоношенного ребенка способен выработать достаточный иммунный ответ на вакцинные антигены, в связи с чем таких детей необходимо безотлагательно вакцинировать для предотвращения тяжелого течения инфекционных процессов, свойственного детям, рожденным раньше срока. Для уменьшения разногласий, затрудняющих своевременную иммунизацию, нужны федеральные клинические рекомендации по вакцинации недоношенных с подробными разъяснениями; для некоторых вакцин необходимы особые схемы введения, учитывающие сниженную иммуногенность в данной группе.

The article analyzes the recommended immunization schedule for premature babies. Due to the large number of routine medical disruptions this topic is extremely relevant in the Russian Federation today. Based on the modern scientific data the authors identified the difficulties of immunization of premature babies leading to an unreasonable delay in vaccination, also they assessed the safety and efficacy of vaccination of premature babies. They proved that the body of a premature baby develops a sufficient immune response to vaccine antigens, and therefore these children must be vaccinated without delay to prevent the severe course of infectious processes inherent in premature children. To reduce the controversy impeding timely immunization, there is a need for federal clinical guidelines for vaccination of premature babies with detailed explanations; some vaccines require special administration regimens, taking into account the reduced immunogenicity in this group.

недоношенные детииммунизацияграфик вакцинациибезопасностьэффективностьpremature babiesimmunizationvaccination schedulesafetyefficacyReferencesТаточенко В.К. Вакцинация недоношенных и маловесных детей. Педиатрическая фармакология 2013; 10 (4): 30–36.Tatochenko V.K. Vaccination of premature/ low-birth-weight children. Pediatricheskaya farmakologiya 2013;10(4): 30–36. (in Russ.)Союз педиатров России. Клинические рекомендации по вакцинопрофилактике пневмококковой инфекции у детей, 2018. https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/СПРВакцинацияпневмококк2018_без_правок.pdf. Ссылка активна на 21.05.2021 г.Russian Union of Pediatricians. Federal clinical guidelines on preventive vaccination against pneumococcal infections in children, 2018. (in Russ.)Rodriguez B.F., Mascaraque L.R., Fraile L.R., Perez I.C., Kuder K. Streptococcus pneumoniae: the forgotten microorganism in neonatal sepsis. Fetal Pediatr Pathol 2015; 34(3): 202–205. DOI: 10.3109/15513815.2015.1033073Rodriguez B.F., Mascaraque L.R., Fraile L.R., Perez I.C., Kuder K. Streptococcus pneumoniae: the forgotten microorganism in neonatal sepsis. Fetal Pediatr Pathol 2015; 34(3): 202–205. DOI: 10.3109/15513815.2015.1033073Langkamp D.L., Davis J.P. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 1996; 128: 654–659. DOI: 10.1016/s0022-3476(96)80131-4Langkamp D.L., Davis J.P. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 1996; 128: 654–659. DOI: 10.1016/s0022-3476(96)80131-4Manzoni P., Calzedda R., Altieri E., Herrera M.A.P., Fioretti M., Farina D. Issues of vaccination in premature infants: an overview. Ital J Pediatr 2015; 41: A20. DOI: 10.1186/1824-7288-41-S1-A20Manzoni P., Calzedda R., Altieri E., Herrera M.A.P., Fioretti M., Farina D. Issues of vaccination in premature infants: an overview. Ital J Pediatr 2015; 41: A20. DOI: 10.1186/1824-7288-41-S1-A20Cortese M.M., Parashar U.D., Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58(RR-2): 1–25Cortese M.M., Parashar U.D., Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58(RR-2): 1–25Приказ Министерства здравоохранения Российской Федерации от 18 декабря 1997 г. № 375 (ред. от 30.12.1998 г.) «О Календаре профилактических прививок». Приложение 4 «Перечень медицинских противопоказаний к проведению профилактических прививок». https://docs.cntd.ru/document/901702354. Ссылка активна на 21.05.2021 г.Order of the Ministry of Health of the Russian Federation No. 375 dated 18.12.1997g. (as amended on 30.12.1998) «Calendar of Preventive Vaccinations». Appendix 4 «List of medical contraindications for preventive vaccinations». (in Russ.)«МУ 3.3.1.1095-02. 3.3.1. Вакцинопрофилактика. Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок. Методические указания», утвержденные Главным государственным санитарным врачом Российской Федерации 9 января 2002 г. https://legalacts.ru/doc/mu-3311095-02-331-vaktsinoprofilaktika-meditsinskie-protivopokazanija-k. Ссылка активна на 21.05.2021 г.Guidelines 3.3.1.1095-02. 3.3.1. Vaccine prevention. Medical contraindications for prophylactic vaccination with the national vaccination calendar. Approved by the Chief State Sanitary Doctor of the Russian Federation on January 9, 2002. (in Russ.)Chiappini E., Petrolini C., Sandini E., Licari A., Pugni L., Mosca F. et al. Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology. Expert Rev Vaccines 2019; 18 (5): 523–545. DOI: 10.1080/14760584.2019.1604230Chiappini E., Petrolini C., Sandini E., Licari A., Pugni L., Mosca F. et al. Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology. Expert Rev Vaccines 2019; 18 (5): 523–545. DOI: 10.1080/14760584.2019.1604230Методические рекомендации. Иммунопрофилактика инфекционных болезней у недоношенных детей. Под ред. А.А. Баранова, Л.С. Намазовой-Барановой, И.А. Беляевой, И.В. Давыдовой, Н.Н. Володина, Е.А. Вишневой и др. Москва: ПедиатрЪ, 2019; 51.Clinical guidelines. Immunoprophylaxis of infectious diseases in premature infants. Editors A.A. Baranov, Namazova-L.S. Baranova, I.A. Belyaeva, I.V. Davydova, N.N. Volodin, E.A. Vishneva et al . Moscow: Pediatr, 2019; 51. (in Russ.)Melville J.M., Moss T.J. The immune consequences of preterm birth. Front. Neurosci 2013; 7 (79): 1–9. DOI: 10.3389/fnins.2013.00079Melville J.M., Moss T.J. The immune consequences of preterm birth. Front. Neurosci 2013; 7 (79): 1–9. DOI: 10.3389/fnins.2013.00079Gagneur A., Pinquier D., Quach C. Immunization of preterm infants. Hum Vaccin Immunother 2015; 11 (11): 2556–2563. DOI: 10.1080/21645515.2015.1074358Gagneur A., Pinquier D., Quach C. Immunization of preterm infants. Hum Vaccin Immunother 2015; 11 (11): 2556–2563. DOI: 10.1080/21645515.2015.1074358Sharma A.A., Jen R., Butler A., Lavoie P.M. The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol 2012; 145 (1): 61–68. DOI: 10.1016/j.clim.2012.08.006Sharma A.A., Jen R., Butler A., Lavoie P.M. The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol 2012; 145 (1): 61–68. DOI: 10.1016/j.clim.2012.08.006Анциферова Е.В., Таранушенко Т.Е., Кустова Т.В., Овчинникова Т.В., Васильева Е.М., Королева Д.А. Вакцинация недоношенных детей. Педиатрия им. Г.Н. Сперанского 2020; 99 (1): 111–116.Anciferova E.V., Taranushenko T.E., Kustova T.V., Ovchinnikova T.V., Vasil’eva E.M., Koroleva D.A. Vaccination for preterm infants. Pediatriya im. G.N. Speranskogo. 2020; 99 (1): 111–116. (in Russ.)Дегтярева М.В. Иммунитет новорожденных в норме и при патологии. Лекция для практикующих врачей. ГОУ ВПО РГМУ Росздрава, Москва, 2010; 25.Degtjareva M.V. The immune system of newborn: normal and pathological conditions. Lektsiya dlya praktikuyushchikh vrachei. GOU VPO RGMU Roszdrava, Moskva, 2010; 25. (in Russ.)Esposito S., Fumagalli M., Principi N. Immunogenicity, safety and tolerability of vaccinations in premature infants. Expert Rev Vaccines 2012; 11 (10): 1199–209. DOI: 10.1586/erv.12.93Esposito S., Fumagalli M., Principi N. Immunogenicity, safety and tolerability of vaccinations in premature infants. Expert Rev Vaccines 2012; 11 (10): 1199–209. DOI: 10.1586/erv.12.93Simon A.K., Hollander G.A., McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 2015; 282(1821): 20143085. DOI: 10.1098/rspb.2014.3085Simon A.K., Hollander G.A., McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 2015; 282(1821): 20143085. DOI: 10.1098/rspb.2014.3085Устьянцева Л.С., Чистякова Г.Н., Ремизова И.И., Захарова С.Ю., Шамова К.П., Бычкова С.В. Особенности врожденного и адаптивного иммунитета недоношенных детей с тяжелым гипоксически-ишемическим поражением центральной нервной системы. Российский вестник перинатологии и педиатрии 2017; 62(3): 59–65. DOI: 10.21508/1027-4065-2017-62-3-59-65Ust’janceva L.S., Chistjakova G.N., Remizova I.I., Zaharova S.Yu., Shamova K.P., Bychkova S.V. Features of innate and adaptive immunity in preterm infants with hypoxic-ischemic lesions of the central nervous system. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2017; 62(3): 59–65. (in Russ.) DOI: 10.21508/1027-4065-2017-62-3-59-65Berrington J.E., Barge D., Fenton A.C., Cant A.J., Spickett G.P. Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analyzed by single platform flow cytometry. Clin Exp Immunol 2005; 140 (2): 289–292. DOI: 10.1111/j.1365-2249.2005.02767.xBerrington J.E., Barge D., Fenton A.C., Cant A.J., Spickett G.P. Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analyzed by single platform flow cytometry. Clin Exp Immunol 2005; 140 (2): 289–292. DOI: 10.1111/j.1365-2249.2005.02767.xVan den Berg J.P., Westerbeek E.A.M., van der Klis F.R., Berbers G.A., van Elburg R.M. Transplacental transport of IgG antibodies to preterm infants: A review of the literature. Hum Vaccin 2011; 87 (2): 67–72. DOI: 10.1016/j.earlhumdev.2010.11.003Van den Berg J.P., Westerbeek E.A.M., van der Klis F.R., Berbers G.A., van Elburg R.M. Transplacental transport of IgG antibodies to preterm infants: A review of the literature. Hum Vaccin 2011; 87 (2): 67–72. DOI: 10.1016/j.earlhumdev.2010.11.003Sisson H. Vaccinating preterm infants: why the delay? Infant 2014; 10(3): 84–86Sisson H. Vaccinating preterm infants: why the delay? Infant 2014; 10(3): 84–86Baxter D. Vaccine responsiveness in premature infants. Hum Vaccin 2010; 6(6): 506–511. DOI: 10.4161/hv.6.6.12083Baxter D. Vaccine responsiveness in premature infants. Hum Vaccin 2010; 6(6): 506–511. DOI: 10.4161/hv.6.6.12083D’Angio C. Active immunization of premature and low birth-weight infants: A review of immunogenicity, efficacy, and tolerability. Paediatr Drugs 2007; 9(1): 17–32. DOI: 10.2165/00148581-200709010-00003D’Angio C. Active immunization of premature and low birth-weight infants: A review of immunogenicity, efficacy, and tolerability. Paediatr Drugs 2007; 9(1): 17–32. DOI: 10.2165/00148581-200709010-00003Rouers E.D.M., Bruijning-Verhagen P.C.J., van Gageldonk P.G.M., van Dongen J.A.P., Sanders E.A.M., Berbers G.A.M. Association of Routine Infant Vaccinations with Antibody Levels among Preterm Infants. JAMA 2020; 324(11): 1068–1077. DOI: 10.1001/jama.2020.12316Rouers E.D.M., Bruijning-Verhagen P.C.J., van Gageldonk P.G.M., van Dongen J.A.P., Sanders E.A.M., Berbers G.A.M. Association of Routine Infant Vaccinations with Antibody Levels among Preterm Infants. JAMA 2020; 324(11): 1068–1077. DOI: 10.1001/jama.2020.12316Харит С.М., Каплина С.П., Рулева А.А., Фридман И.В., Скрипченко Н.В. Недоношенные дети: безопасность вакцинации и специфический иммунный ответ. Эпидемиология и вакцинопрофилактика 2015; 14(4): 61–66.Harit S.M., Kaplina S.P., Ruleva A.A., Fridman I.V., Skripchenko N.V. Prematurely Born Children: Vaccination – Safety and Specific Immune Response. Epidemiologiya i vaktsinoprofilaktika 2015; 14(4): 61–66. (in Russ.)Pfister R.E., Aeschbach V., Niksic-Stuber V., Martin B.C., Siegrist C.A. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr 2004; 145: 58–66. DOI: 10.1016/j.jpeds.2004.04.006Pfister R.E., Aeschbach V., Niksic-Stuber V., Martin B.C., Siegrist C.A. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr 2004; 145: 58–66. DOI: 10.1016/j.jpeds.2004.04.006Schulzke S., Heininger U., Lucking-Famira M., Fahnenstich H. Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr 2005; 164: 432–435. DOI: 10.1007/s00431-005-1674-3Schulzke S., Heininger U., Lucking-Famira M., Fahnenstich H. Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr 2005; 164: 432–435. DOI: 10.1007/s00431-005-1674-3Klein N.P., Massolo M.L., Greene J., Dekker C.L., Black S., Escobar G.J. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008; 121: 463–469. DOI: 10.1542/peds.2007-1462Klein N.P., Massolo M.L., Greene J., Dekker C.L., Black S., Escobar G.J. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008; 121: 463–469. DOI: 10.1542/peds.2007-1462Saari T.N. American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 2003; 112(1 Pt 1): 193–198. DOI: 10.1542/peds.112.1.193Saari T.N. American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 2003; 112(1 Pt 1): 193–198. DOI: 10.1542/peds.112.1.193Gaudelus J., Lefèvre-Akriche S., Roumegoux C., Bolie S., Belasco C., Letamendia-Richard E., Lachassinne E. Immunization of the preterm infant. Arch Pediatr 2007; 14: S24–30. DOI: 10.1016/s0929-693x(07)80007-8Gaudelus J., Lefèvre-Akriche S., Roumegoux C., Bolie S., Belasco C., Letamendia-Richard E., Lachassinne E. Immunization of the preterm infant. Arch Pediatr 2007; 14: S24–30. DOI: 10.1016/s0929-693x(07)80007-8Centers for Disease Control and Prevention. Concurrent Administration of Antimicrobial Agents and Vaccines. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html. Ссылка активна на 21.05.2021 гCenters for Disease Control and Prevention. Concurrent Administration of Antimicrobial Agents and Vaccines. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html.Government of Canada. Immunization of infants born prematurely: Canadian Immunization Guide. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-5-immunization-infants-born-prematurely.html. Ссылка активна на 21.05.2021 гGovernment of Canada. Immunization of infants born prematurely: Canadian Immunization Guide. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-5-immunization-infants-born-prematurely.html.Таточенко В.К., Озерецковский Н.А. Иммунопрофилактика-2020. Cправочник. 14-е изд., расш. М.: ПедиатрЪ, 2020; 274 с.Tatochenko VK, Ozeretskovskii NA. Immunoprophylaxis-2020. Spravochnik. 14th ed., enlarged. Moscow: Pediatr, 2020; 274 p. (in Russ.)Российское общество фтизиатров. Федеральные клинические рекомендации по вакцинопрофилактике туберкулеза у детей, 2015. https://roftb.ru/netcat_files/doks2017/kl_5.pdf. Ссылка активна на 21.05.2021 г.Russian Union of Phthisiatricians. Bacille Calmette-Guérin Vaccination in children. Federal сlinical practice guidelines, 2015. (in Russ.)Союз педиатров России. Клинические рекомендации по вакцинопрофилактике ротавирусной инфекции у детей, 2017. https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/Ротавирус_вакц_клинреки_2017.pdf, ссылка активна на 21.05.2021 г.Russian Union of Pediatricians. Federal clinical guidelines on preventive vaccination against rotavirus infections in children, 2017 (in Russ.)European Centre for Disease Prevention and Control. Vaccine Scheduler. Germany: Recommended vaccinations. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=6&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=false. Cсылка активна на 21.05.2021 гEuropean Centre for Disease Prevention and Control. Vaccine Scheduler. Germany: Recommended vaccinations. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=6&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=false.Kent A., Ladhani S.N., Andrews N.J., Scorrer T., Pollard A.J., Clarke P. et al. PUNS Study Group. Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT. Pediatrics 2016; 138(3): e20153945. DOI: 10.1542/peds.2015-3945Kent A., Ladhani S.N., Andrews N.J., Scorrer T., Pollard A.J., Clarke P. et al. PUNS Study Group. Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT. Pediatrics 2016; 138(3): e20153945. DOI: 10.1542/peds.2015-3945Martinón-Torres F., Czajka H., Center K.J., Wysocki J., Majda-Stanislawska E., Omeñaca F. et al. 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants. Pediatrics 2015; 135(4): 876–886. DOI: 10.1542/peds.2014-2941Martinón-Torres F., Czajka H., Center K.J., Wysocki J., Majda-Stanislawska E., Omeñaca F. et al. 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants. Pediatrics 2015; 135(4): 876–886. DOI: 10.1542/peds.2014-2941Hviid A. Effectiveness of two pertussis vaccines in preterm Danish children. Vaccine 2009; 27(23):3035–3038. DOI: 10.1016/j.vaccine.2009.03.041Hviid A. Effectiveness of two pertussis vaccines in preterm Danish children. Vaccine 2009; 27(23):3035–3038. DOI: 10.1016/j.vaccine.2009.03.041Omeñaca F., Garcia-Sicilia J., García-Corbeira P., Boceta R., Romero A., Lopez G. et al. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116(6): 1292-1298. DOI: 10.1542/peds.2004-2336Omeñaca F., Garcia-Sicilia J., García-Corbeira P., Boceta R., Romero A., Lopez G. et al. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116(6): 1292-1298. DOI: 10.1542/peds.2004-2336Vázquez L., Garcia F., Rüttimann R., Coconier G., Jacquet J.M., Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr 2008; 97(9): 1243–1249. DOI: 10.1111/j.1651-2227.2008.00884.xVázquez L., Garcia F., Rüttimann R., Coconier G., Jacquet J.M., Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr 2008; 97(9): 1243–1249. DOI: 10.1111/j.1651-2227.2008.00884.xD’Angio C.T., Maniscalco W.M., Pichichero M.E. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995; 96: 18–22D’Angio C.T., Maniscalco W.M., Pichichero M.E. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995; 96: 18–22Новикова Д.А., Намазова-Баранова Л.С., Айворонская А.Г., Броева М.И., Федосеенко М.В. Оценка безопасности применения пентавакцины у недоношенных детей: опыт центра семейной вакцинопрофилактики. Вопросы современной педиатрии 2015; 14(3): 392–395. DOI: 10.15690/vsp.v14i3.1376Novikova D.A.,Namazova-Baranova L.S.,Gayvoronskaya A.G., Broeva M.I., Fedoseenko M.V. Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment. Voprosy sovremennoi pediatrii 2015; 14 (3): 392–395. (in Russ.) DOI: 10.15690/vsp.v14i3.1376Slack M.H., Cade S., Schapira D., Thwaites R.J., Crowley-Luke A., Southern J. et al. DT5aP-Hib-IPV and MCC vaccines: preterm infants’ response to accelerated immunisation. Arch Dis Child 2005; 90: 338–334. DOI: 10.1136/adc.2004.052720Slack M.H., Cade S., Schapira D., Thwaites R.J., Crowley-Luke A., Southern J. et al. DT5aP-Hib-IPV and MCC vaccines: preterm infants’ response to accelerated immunisation. Arch Dis Child 2005; 90: 338–334. DOI: 10.1136/adc.2004.052720Союз педиатров России. Клинические рекомендации по иммунопрофилактике респираторно-синцитиальной вирусной инфекции у детей, 2016. https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/СПРФедеррекомиммунизацияРСВ2015.pdf. Ссылка активна на 21.05.2021 г.Russian Union of Pediatricians. Immunoprophylaxis of Respiratory Syncytial Virus infection in children. Federal clinical practice guidelines, 2016. (in Russ.)

The authors declare that there are no conflicts of interest present.